Marco Rossi

Mr. Marco Rossi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2018 in Genes
Verified
Journal Article
Open access
PDF file
FBFaraz Bishehsari
Faraz Bishehsari
PEPhillip A Engen
Phillip A Engen
NPNailliw Z. Preite
Nailliw Z. Preite
Yunus Emre TunçilYunus Emre Tunçil
Yunus Emre Tunçil
ANAnkur Naqib
Ankur Naqib
AKAli Keshavarzian
Ali Keshavarzian
Epidemiological studies propose a protective role for dietary fiber in colon cancer (CRC). One possible mechanism of fiber is its fermentation property in the gut and ability to change microbiota composition and function. Here, we investigate the role of a dietary fiber mixture in polyposis and elucidate potential mechanisms using TS4Cre × cAPCl°x468 mice. Stool microbiota profiling was performed, while functional prediction was done using PICRUSt. Stool short-chain fatty acid (SCFA) metabolites were measured. Histone acetylation and expression of SCFA butyrate receptor were assessed. We found that SCFA-producing bacteria were lower in the polyposis mice, suggesting a decline in the fermentation product of dietary fibers with polyposis. Next, a high fiber diet was given to polyposis mice, which significantly increased SCFA-producing bacteria as well as SCFA levels. This was associated with an increase in SCFA butyrate receptor and a significant decrease in polyposis. In conclusion, we found polyposis to be associated with dysbiotic microbiota characterized by a decline in SCFA-producing bacteria, which was targetable by high fiber treatment, leading to an increase in SCFA levels and amelioration of polyposis. The prebiotic activity of fiber, promoting beneficial bacteria, could be the key mechanism for the protective effects of fiber on colon carcinogenesis. SCFA-promoting fermentable fibers are a promising dietary intervention to prevent CRC.

30 January 2018 in Cancers
Verified
Journal Article
Open access
PDF file
MRMarco Rossi
Marco Rossi
MAMuhammad Anwar
Muhammad Anwar
AUAhmad Usman
Ahmad Usman
AKAli Keshavarzian
Ali Keshavarzian
FBFaraz Bishehsari
Faraz Bishehsari
Colorectal cancer (CRC) is a major cause of morbidity and mortality, being the third most common cancer diagnosed in both men and women in the world. Several environmental and habitual factors have been associated with the CRC risk. Alcohol intake, a common and rising habit of modern society, is one of the major risk factors for development of CRC. Here, we will summarize the evidence linking alcohol with colon carcinogenesis and possible underlying mechanisms. Some epidemiologic studies suggest that even moderate drinking increases the CRC risk. Metabolism of alcohol involves ethanol conversion to its metabolites that could exert carcinogenic effects in the colon. Production of ethanol metabolites can be affected by the colon microbiota, another recently recognized mediating factor to colon carcinogenesis. The generation of acetaldehyde and alcohol’s other metabolites leads to activation of cancer promoting cascades, such as DNA-adduct formation, oxidative stress and lipid peroxidation, epigenetic alterations, epithelial barrier dysfunction, and immune modulatory effects. Not only does alcohol induce its toxic effect through carcinogenic metabolites, but alcoholics themselves are predisposed to a poor diet, low in folate and fiber, and circadian disruption, which could further augment alcohol-induced colon carcinogenesis.

29 March 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
Kevinn EddyKevinn Eddy
Kevinn Eddy
KGKajal Gupta
Kajal Gupta
JPJeffrey C. Pelletier
Jeffrey C. Pelletier
AIAllison L. Isola
Allison L. Isola
CMChristina Marinaro
Christina Marinaro
SCSuzie Chen
Suzie Chen
Mouse models that reflect human disorders provide invaluable tools towards the translation of basic science discoveries to clinical therapies. However, many of these in vivo therapeutic studies are short-term and do not accurately mimic patient conditions. In this study, we utilized a fully immuno-competent, transgenic mouse model, TGS, in which the spontaneous development of metastatic melanoma is driven by the ectopic expression of a normal neuronal receptor, metabotropic glutamate receptor 1 (mGluR1), as a model to assess longitudinal treatment response (up to 8 months) with an inhibitor of glutamatergic signaling, troriluzole, a prodrug of riluzole, plus an antibody against programmed cell death protein-1 (PD-1), an immune-checkpoint inhibitor. Our results reveal a sex-biased treatment response that led to an improved survival in troriluzole and/or anti-PD-1 treated male mice that correlated with differential CD8+ T-cells and CD11b+ myeloid cell populations in the tumor-stromal interface, supporting the notion that this model is a responsive and tractable system for evaluating therapeutic regimens for melanoma in an immuno-competent setting.

12 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MRMarco Rossi
Marco Rossi
SASalvatore M. Aspromonte
Salvatore M. Aspromonte
FKFrederick J. Kohlhapp
Frederick J. Kohlhapp
JNJenna H. Newman
Jenna H. Newman
ALAlex Lemenze
Alex Lemenze
Andrew ZlozaAndrew Zloza
Andrew Zloza
Through a multitude of studies, the gut microbiota has been recognized as a significant influencer of both homeostasis and pathophysiology. Certain microbial taxa can even affect treatments such as cancer immunotherapies, including the immune checkpoint blockade. These taxa can impact such processes both individually as well as collectively through mechanisms from quorum sensing to metabolite production. Due to this overarching presence of the gut microbiota in many physiological processes distal to the GI tract, we hypothesized that mice bearing tumors at extraintestinal sites would display a distinct intestinal microbial signature from non-tumor-bearing mice, and that such a signature would involve taxa that collectively shift with tumor presence. Microbial OTUs were determined from 16S rRNA genes isolated from the fecal samples of C57BL/6 mice challenged with either B16-F10 melanoma cells or PBS control and analyzed using QIIME. Relative proportions of bacteria were determined for each mouse and, using machine-learning approaches, significantly altered taxa and co-occurrence patterns between tumor- and non-tumor-bearing mice were found. Mice with a tumor had elevated proportions of Ruminococcaceae, Peptococcaceae.g_rc4.4, and Christensenellaceae, as well as significant information gains and ReliefF weights for Bacteroidales.f__S24.7, Ruminococcaceae, Clostridiales, and Erysipelotrichaceae. Bacteroidales.f__S24.7, Ruminococcaceae, and Clostridiales were also implicated through shifting co-occurrences and PCA values. Using these seven taxa as a melanoma signature, a neural network reached an 80% tumor detection accuracy in a 10-fold stratified random sampling validation. These results indicated gut microbial proportions as a biosensor for tumor detection, and that shifting co-occurrences could be used to reveal relevant taxa.

1 May 2018 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
FBFaraz Bishehsari
Faraz Bishehsari
PEPhillip A Engen
Phillip A Engen
NPNailliw Z. Preite
Nailliw Z. Preite
Yunus Emre TunçilYunus Emre Tunçil
Yunus Emre Tunçil
ANAnkur Naqib
Ankur Naqib
AKAli Keshavarzian
Ali Keshavarzian

29 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MRMarco Rossi
Marco Rossi
MAMuhammad Anwar
Muhammad Anwar
AUAhmad Usman
Ahmad Usman
AKAli Keshavarzian
Ali Keshavarzian
FBFaraz Bishehsari
Faraz Bishehsari
There was a mistake in the introduction section as published